Waterford, Ireland

Marta Golec

USPTO Granted Patents = 3 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2021-2025

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Marta Golec: Innovator in Pediatric Dosage Forms

Introduction

Marta Golec is a prominent inventor based in Waterford, Ireland. She has made significant contributions to the field of pharmaceuticals, particularly in the development of pediatric dosage forms. With a total of three patents to her name, Golec is recognized for her innovative approaches to medication delivery for children.

Latest Patents

Marta Golec's latest patents include advancements in pediatric dosage forms, specifically focusing on methods of making and using modified release dosage forms of vitamin D compounds. These patents detail the processes involved in creating effective and safe dosage forms tailored for pediatric patients. The innovations aim to improve the administration of vitamin D, ensuring that children receive the necessary nutrients in a manner that is both effective and user-friendly.

Career Highlights

Golec is currently associated with Eirgen Pharma Ltd., where she continues to push the boundaries of pharmaceutical innovation. Her work has been instrumental in enhancing the quality of pediatric healthcare through improved medication formulations. Golec's dedication to her field is evident in her commitment to developing solutions that cater specifically to the needs of young patients.

Collaborations

Marta Golec collaborates with esteemed colleagues such as Praful Balavant Deshpande and Stephen James Quinlan. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further driving innovation in pediatric medicine.

Conclusion

Marta Golec stands out as a key figure in the realm of pediatric pharmaceuticals, with her innovative patents and collaborative efforts contributing to the advancement of healthcare for children. Her work exemplifies the importance of targeted medication solutions in improving health outcomes for young patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…